Sign in
8-K

Current Report

Avalo Therapeutics, Inc. Filed Acc 0001628280-23-033629

Director nominations

  • Item 5.08 Shareholder director nominations

From the SEC's structured data for this filing

Loading avtx-20231003.htm…